World Health Organization Says No To Delayed Disclosure Of Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
The World Health Organization has decided that the public's need for transparency in clinical trials trumps industry concerns that early disclosure of certain information could undercut a company's competitive advantage